Evidence map›Paper›PMID 31895148›Full record

ArticleAIDS (London, England)2020

Machine-learning classification of neurocognitive performance in children with perinatal HIV initiating de novo antiretroviral therapy.

Robert H Paul, Kyu S Cho, Andrew C Belden, Claude A Mellins, Kathleen M Malee, Reuben N Robbins, Lauren E Salminen, Stephen J Kerr, Badri Adhikari, Paola M Garcia-Egan and 16 more

Open access · greenAbstract read
In one paragraph

Article in AIDS (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Cognitive Phenotypes of HIV Defined Using a Novel Data-driven Approach.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2022
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 16 institutions in 4 countries.

Robert H PaulMissouri Institute of Mental Health, University of Missouri-St. Louis, Missouri.
Kyu S ChoMissouri Institute of Mental Health, University of Missouri-St. Louis, Missouri.
Andrew C BeldenMissouri Institute of Mental Health, University of Missouri-St. Louis, Missouri.
Claude A MellinsHIV Center for Clinical and Behavioral Studies, New York State Psychiatric Institute, and Columbia University, New York.
Kathleen M MaleeDepartment of Psychiatry and Behavioral Science, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Reuben N RobbinsHIV Center for Clinical and Behavioral Studies, New York State Psychiatric Institute, and Columbia University, New York.
Lauren E SalminenImaging Genetics Center, Stevens Neuroimaging and Informatics Institute, University of Southern California, Marina del Rey, California, USA.
Stephen J KerrHIV Netherlands Australia Thailand (HIV-NAT) Research Collaboration, Thai Red Cross AIDS Research Center.
Badri AdhikariDepartment of Mathematics and Computer Science, University of Missouri-St. Louis, Missouri, USA.
Paola M Garcia-EganMissouri Institute of Mental Health, University of Missouri-St. Louis, Missouri.
Jiratchaya SophonphanHIV Center for Clinical and Behavioral Studies, New York State Psychiatric Institute, and Columbia University, New York.
Linda AurpibulResearch Institute for Health Sciences.
Kulvadee ThongpibulDepartment of Psychology, Faculty of Humanities, Chiang Mai University, Chiang Mai.
Pope KosalaraksaDepartment of Pediatrics, Faculty of Medicine, Khon Kaen University, Khon Kaen.
Suparat KanjanavanitNakornping Hospital, Chiang Mai.
Chaiwat NgampiyaskulPrapokklao Hospital, Chanthaburi.
Jurai WongsawatBamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand.
Saphonn VonthanakUniversity of Health Science, Phnom Penh, Cambodia.
Tulathip SuwanlerkHIV Netherlands Australia Thailand (HIV-NAT) Research Collaboration, Thai Red Cross AIDS Research Center.
Victor G ValcourMemory and Aging Center, Department of Neurology, University of California, San Francisco, California.
Rebecca N Preston-CampbellMissouri Institute of Mental Health, University of Missouri-St. Louis, Missouri.
Jacob D BolzeniousMissouri Institute of Mental Health, University of Missouri-St. Louis, Missouri.
Merlin L RobbHenry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, USA.
Jintanat AnanworanichHenry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, USA.
Thanyawee PuthanakitHIV Netherlands Australia Thailand (HIV-NAT) Research Collaboration, Thai Red Cross AIDS Research Center.
PREDICT Study Group
University of Missouri–St. Louis · USHenry M. Jackson Foundation · USHIV Netherlands Australia Thailand Research Collaboration · THNew York Psychoanalytic Society and Institute · USBamrasnaradura Infectious Diseases Institute · THChiang Mai University · THChulalongkorn University · THColumbia University · USKhon Kaen University · THMissouri Institute of Mental Health · USNakornping Hospital · THNorthwestern University · USPrapokklao Hospital · THUniversity of California, San Francisco · USUniversity of Health Science · KHUniversity of Southern California · US

Funding

Treatment of HIV/Tuberculosis Co-DiseaseU19AI053741 · NIAID · HIV-NAT, THE THAI RED CROSS AIDS RCH CTR · PI RUXRUNGTHAM, KIAT · 2004 to 2010
$6.3M
Viral and Host Determinants of Cognitive Status in Vertically Transmitted HIVR01MH108559 · NIMH · UNIVERSITY OF MISSOURI-ST. LOUIS · PI PAUL, ROBERT HARRIS · 2017 to 2021
$3.4M
Neurodevelopment and Imaging among HIV-infected Children from the PREDICT studyR01MH089722 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI VALCOUR, VICTOR · 2010 to 2014
$3.1M
The Latent HIV Reservoir in Early-treated Thai ChildrenR01AI114236 · NIAID · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI PUTHANAKIT, THANYAWEE, ROBB, MERLIN L · 2014 to 2018
$2.8M
Determinants of Resilience in Youth with HIV infection and Youth affected by HIVR01MH102151 · NIMH · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI ROBB, MERLIN L · 2014 to 2018
$2.3M
Predictors of Immunologic Long-term Non-Progression in Children with HIVR01AI075408 · NIAID · HIV-NAT, THE THAI RED CROSS AIDS RCH CTR · PI ANANWORANICH, JINTANAT · 2007 to 2010
$318k
NIAID NIH HHS R01 AI075408NIAID NIH HHS U19 AI053741NIMH NIH HHS R01 MH089722NIMH NIH HHS R01 MH102151NIMH NIH HHS R01 MH108559
6 · The paper itself

Abstract

objectiveTo develop a predictive model of neurocognitive trajectories in children with perinatal HIV (pHIV).

designMachine learning analysis of baseline and longitudinal predictors derived from clinical measures utilized in pediatric HIV.

methodsTwo hundred and eighty-five children (ages 2-14 years at baseline; Mage = 6.4 years) with pHIV in Southeast Asia underwent neurocognitive assessment at study enrollment and twice annually thereafter for an average of 5.4 years. Neurocognitive slopes were modeled to establish two subgroups [above (n = 145) and below average (n = 140) trajectories). Gradient-boosted multivariate regressions (GBM) with five-fold cross validation were conducted to examine baseline (pre-ART) and longitudinal predictive features derived from demographic, HIV disease, immune, mental health, and physical health indices (i.e. complete blood count [CBC]).

resultsThe baseline GBM established a classifier of neurocognitive group designation with an average AUC of 79% built from HIV disease severity and immune markers. GBM analysis of longitudinal predictors with and without interactions improved the average AUC to 87 and 90%, respectively. Mental health problems and hematocrit levels also emerged as salient features in the longitudinal models, with novel interactions between mental health problems and both CD4 cell count and hematocrit levels. Average AUCs derived from each GBM model were higher than results obtained using logistic regression.

conclusionOur findings support the feasibility of machine learning to identify children with pHIV at risk for suboptimal neurocognitive development. Results also suggest that interactions between HIV disease and mental health problems are early antecedents to neurocognitive difficulties in later childhood among youth with pHIV.

Indexed as

Infectious Disease Transmission, VerticalMachine LearningAlgorithmsCD4 Lymphocyte CountChildChild, PreschoolCognitionExecutive FunctionFemaleHIV InfectionsHumansMaleMental HealthParturitionPregnancyPsychomotor Performance

Identifiers

PMID31895148
PMCPMC7072001
OpenAlexW2997112610

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.